In NSCLC, the most common mutations occur in the TP53 gene encoding the tumor suppressor p53 (in almost 50% of cases), and these alterations are associated with a worse prognosis and may be relatively more resistant to chemotherapy and radiation [117]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.